drugset / Trial / NCT01451645

Efficacy and Safety of Colchicine for the Prevention of Gout Flares During the Initiation of Allopurinol

NCT01451645

Phase 4 Completed 82 enrolled Regeneron Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if once-daily treatment with colchicine, compared to placebo, is effective in preventing gout flares in patients who are initiating therapy with allopurinol.

Timeline

Start
2011-10
Primary completion
2012-08
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Colchicine Small molecule 0.6 mg
Background Allopurinol Small molecule

Indications